Search Results
Jun 15, 2026, 08:57 ET Residence Adds GateMaker, Bringing Creator Economy Expertise to Its Growing Creative Network
the influencer marketing agency.In Their WordsRyan Honey, CEO and Co-Founder of Residence, said: "GateMaker has built something rare in the creator and influencer economy: real relationships and the discipline to activate them at scale. What drew us was the founders' conviction behind
More news about: Residence
Jun 15, 2026, 08:53 ET Slovenian Neo-Soul Sextet SATORI Introduce Themselves to North America With New Single "Walking" and Album 'The Seat of the Soul'
out now on Spotify and all major platforms. For North American listeners discovering them for the first time, SATORI arrive as something genuinely rare: a band steeped in soul, blues, jazz, and pop who have built a sound that feels both warmly familiar and entirely fresh, anchored by the extraordinary
More news about: SATORI
Jun 15, 2026, 08:49 ET Panoplai Appoints Katie Gross as President
"Katie is one of the most accomplished operators in the insights industry. She has spent her career turning data into action, and she brings the rare combination of deep category expertise, platform-building experience, and genuine client trust that this moment requires. As we scale our enterprise
More news about: Panoplai
Jun 15, 2026, 08:44 ET Morphy's July 15-16 Automobilia, Petroliana & Soda Advertising Auction Is Loaded With Nearly 1,300 Lots Of Rare And Desirable Collectibles
Chief Model 347B bike; rare petroliana signsDENVER, Pa., June 15, 2026 /PRNewswire/ -- An exceptionally clean example of a 1940s Harbor Petroleum Products porcelain sign with seaplane graphics; two rare and desirable vintage
More news about: Morphy Auctions
Jun 15, 2026, 08:38 ET Agiloft Names Jason Barnwell as Chief Product Officer, Bringing Rare Convergence of Legal Practice, Engineering, and Enterprise Contracting to AI Product Leadership
billions of dollars in procurement spend across one of the world's most complex supply chains. He joins the product seat with a perspective that is rare in enterprise software: he has been the buyer, the builder, and the practitioner. At Microsoft, Barnwell served most recently as General Manager
More news about: Agiloft
Jun 15, 2026, 08:35 ET Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improved Growth Measures in Pediatric Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2026
#SAT-459)Authors: Ahmed Khattab, M.D., et alAbout Congenital Adrenal HyperplasiaCongenital adrenal hyperplasia (CAH) is a rare genetic condition that results in an enzyme deficiency that alters the production of adrenal steroid hormones, such as cortisol, aldosterone and adrenal
More news about: Neurocrine Biosciences, Inc.
Jun 15, 2026, 08:30 ET Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improvements in Cardiometabolic Outcomes in Adults with Classic Congenital Adrenal Hyperplasia at ENDO 2026
#SAT-459)Authors: Ahmed Khattab, M.D., et alAbout Congenital Adrenal Hyperplasia Congenital adrenal hyperplasia (CAH) is a rare genetic condition that results in an enzyme deficiency that alters the production of adrenal steroid hormones, such as cortisol, aldosterone and adrenal
More news about: Neurocrine Biosciences, Inc.
Jun 15, 2026, 08:00 ET Ramaco Resources Announces Second Quarter Class B Stock Dividend Details
Company's ability to successfully develop the exploratory Brook Mine rare earth and critical mineral project, including whether the Company's exploration target and estimates for such mine are realized, the timing of the initial production of rare earth concentrates, the development of a pilot and ultimately
More news about: Ramaco Resources, Inc.
Jun 15, 2026, 08:00 ET FDA grants Monoamine Oxidase Deficiency Orphan Drug Designation
GALVESTON, Texas, June 15, 2026 /PRNewswire/ -- Families affected by monoamine oxidase deficiency (MAOD), a rare neurodevelopmental disorder, have historically faced delayed diagnosis, limited clinical guidance and scant treatment options. MAOD is an X-linked genetic
More news about: Monoamine Oxidase Deficiency Foundation
Jun 15, 2026, 07:40 ET El Grupo Menarini presenta datos del ensayo de fase 3 SENTRY de selinexor más ruxolitinib en mielofibrosis
desarrollo para una gran variedad de cánceres sólidos y hematológicos.Referencias1. Myelofibrosis. NORD (National Organization for Rare Disorders). https://rarediseases.org/mondo-disease/myelofibrosis/2.
More news about: Menarini Industrie Farmaceutiche Riunite
Jun 15, 2026, 07:00 ET PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes
biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class
More news about: PTC Therapeutics, Inc.
Jun 15, 2026, 07:00 ET Il Gruppo Menarini presenta i dati dello studio di fase 3 SENTRY su selinexor più ruxolitinib nella mielofibrosi in occasione del Congresso 2026 dell'Associazione Europea di Ematologia (EHA)
varie fasi di sviluppo, mirati a diversi tumori solidi ed ematologici.Riferimenti1. Myelofibrosis. NORD (National Organization for Rare Disorders). https://rarediseases.org/mondo-disease/myelofibrosis/2.
More news about: Menarini Industrie Farmaceutiche Riunite
Jun 15, 2026, 07:00 ET Indiana Earns Top Marks, New York Falls Short: Realtor.com®'s 2026 State Report Cards for Homebuilding, Affordability Reveal a Nation Divided
South Carolina (A, 75.2) remains the nation's building champion with a permit-to-population ratio of 1.96, nearly double its population share, and a rare negative new construction premium, meaning newly built homes are actually 5.7% cheaper than existing ones.(4) Texas (A-, 71.0) continues
More news about: Realtor.com
Jun 15, 2026, 06:00 ET Syracuse to Host First-Ever Festival of Orature Celebrating the Region's Young Voices
Director, Mĩcere Gĩthae Mũgo Foundation For philanthropists, civic leaders, and community partners, The Day of Orature presents a rare convergence: youth development, cultural equity and heritage, and downtown civic activation — all in one free, high-visibility public event endorsed
More news about: Mĩcere Gĩthae Mũgo Foundation
Jun 15, 2026, 04:30 ET EZVIZ propose une nouvelle solution d'entrée intelligente avec la sonnette vidéo EP8 Ultra, qui modernise les entrées grâce à une technologie à double objectif et à un écran interactif.
Ultra permet aux utilisateurs de comprendre les situations d'un seul coup d'œil, sans avoir à assembler les informations comme un puzzle.Fait rare sur le marché, l'EP8 Ultra est également équipé d'un écran interactif à IA intégré fonctionnant en mode local, qui propose trois personnages pour une
More news about: EZVIZ
Jun 15, 2026, 03:00 ET Tethis announces application note of SmartBioSurface® slides for cell suspension workflows on leading spatial biology platform
cell-adhesion approach has the potential to preserve cellular morphology and retain complex suspension-cell structures, opening new opportunities to study rare cells, immune-cell interactions, and circulating multi-cellular complexes with enhanced structural and phenotypic clarity." The application
More news about: Tethis S.p.A
Jun 15, 2026, 02:01 ET Lundbeck presents new Phase II asedebart data in Cushing's disease at ENDO 2026
heritage by pursuing biological drug targets within neurohormonal signaling. This area offers the potential to develop differentiated therapeutics for rare endocrine disorders, supported by biomarker-driven patient studies that enable decisive and early development decisions.Preliminary Phase
More news about: H. Lundbeck A/S
Jun 15, 2026, 01:57 ET Lundbeck presents new Phase II asedebart data in Cushing's disease at ENDO 2026
heritage by pursuing biological drug targets within neurohormonal signaling. This area offers the potential to develop differentiated therapeutics for rare endocrine disorders, supported by biomarker-driven patient studies that enable decisive and early development decisions.Preliminary Phase
More news about: H. Lundbeck A/S
Jun 15, 2026, 01:26 ET Menarini Group、European Hematology Association (EHA)の2026年総会にて、骨髄線維症を対象としたセリネキソールとルキソリチニブの併用療法に関する第3相SENTRY試験のデータを発表
同社はまた、乳がんおよび血液がんを適応症とするエラセストラントおよびタグラキソフスプの複数の適応拡大試験も実施しており、固形がんおよび血液がんの多くを対象とする様々な開発段階にある追加の薬剤候補の広範な臨床パイプラインを有しています。参考文献1. 骨髄線維症。NORD (National Organization for Rare Disorders).https://rarediseases.org/mondo-disease/myelofibrosis/2.
More news about: Menarini Industrie Farmaceutiche Riunite
Jun 15, 2026, 00:01 ET Mind the Marketing Gap: Most CMOs Say AI Is Transforming Marketing, But Few Are Using It to Transform Their Own Function
senior partner, and global head of the marketing and customer growth practice. "Marketing organizations are being redesigned around AI, and CMOs have a rare opportunity to drive enterprise value by moving early and optimizing across their own organization as well as their partner ecosystem."Download
More news about: Boston Consulting Group (BCG)
Jun 14, 2026, 16:54 ET GeneDx Holdings Corp. (WGS) Class Action Lawsuit: Investors Face August 3, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
HOLDINGS CORP. CLASS ACTION LAWSUIT – COMPLAINT ALLEGATION SUMMARY:GeneDx provides genetic testing services for diagnosing pediatric and rare diseases. The class period begins on April 16, 2025, when GeneDx announced that it entered into an agreement worth up to $51 million to acquire Fabric
More news about: Kessler Topaz Meltzer & Check, LLP
Jun 14, 2026, 13:17 ET 메나리니 그룹, 2026 유럽혈액학회(EHA) 학술대회에서 골수섬유증 대상 셀리넥서 및 룩소리티닙 병용요법의 제3상 SENTRY 시험 데이터 발표
시험도 진행하고 있으며, 다수의 고형암 및 혈액암을 대상으로 다양한 개발 단계의 추가 신약 후보물질로 구성된 광범위한 임상 파이프라인을 보유하고 있다.참고문헌1. 골수섬유증. NORD(National Organization for Rare Disorders). https://rarediseases.org/mondo-disease/myelofibrosis/2.
More news about: Menarini Industrie Farmaceutiche Riunite
Jun 14, 2026, 07:26 ET Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
marrow, which leads to the formation of scar tissue. This scarring makes it difficult for the body to produce healthy blood cells. The incidence of MF is rare, with only about one or two people diagnosed each year for every 100,000 individuals, and the median survival after diagnosis is six years. Additionally,
More news about: Menarini Industrie Farmaceutiche Riunite
Jun 13, 2026, 22:25 ET Marler Clark Urges Parents to Stop Using Nara Organics Whole Milk Organic Powdered Infant Formula Amid Multistate Infant Botulism Outbreak -- Product Sold Nationwide at Target
Nara Organics outbreak, the implicated product is again a whole-milk powdered formula.About Infant BotulismInfant botulism is a rare but serious illness caused when Clostridium botulinum spores are ingested, germinate in an infant's immature gut, and produce a toxin that attacks the
More news about: Marler Clark, The Food Safety Law Firm
Jun 12, 2026, 17:08 ET Spiro renforce son leadership dans le domaine des activations de marque et de l'événementiel en nommant Karen DeVault au poste de vice-présidente principale en charge des comptes stratégiques internationaux
grande consommation, des technologies, de la fintech, du divertissement, des boissons, du streaming et de la distribution.« Karen possède une rare combinaison de qualités », a déclaré Carley Faircloth-Kilmurray, directrice mondiale du marketing, de la stratégie et des activations chez Spiro. « Elle
More news about: Spiro